ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,494,000 | -9.5% | 120,164 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,651,000 | +85.3% | 120,586 | +0.0% | 0.00% | +100.0% |
| Q2 2016 | $891,000 | +28.9% | 120,573 | +8.1% | 0.00% | 0.0% |
| Q1 2016 | $691,000 | +0.1% | 111,503 | +1.1% | 0.00% | 0.0% |
| Q4 2015 | $690,000 | +8.2% | 110,341 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $638,000 | -27.5% | 109,197 | +2.6% | 0.00% | 0.0% |
| Q2 2015 | $880,000 | -2.2% | 106,405 | -2.6% | 0.00% | 0.0% |
| Q1 2015 | $900,000 | +24.3% | 109,247 | +3.6% | 0.00% | 0.0% |
| Q4 2014 | $724,000 | +24.4% | 105,410 | -2.2% | 0.00% | 0.0% |
| Q3 2014 | $582,000 | -13.5% | 107,800 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $673,000 | +1429.5% | 105,701 | +1856.7% | 0.00% | – |
| Q1 2014 | $44,000 | +18.9% | 5,402 | 0.0% | 0.00% | – |
| Q4 2013 | $37,000 | -99.1% | 5,402 | -97.6% | 0.00% | -100.0% |
| Q3 2013 | $4,207,000 | -47.9% | 228,670 | -50.4% | 0.01% | -53.3% |
| Q2 2013 | $8,069,000 | – | 461,337 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |